US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 11.4100
  • -0.7600-6.24%
Close Dec 20 16:00 ET
  • 11.4100
  • 0.00000.00%
Post 20:05 ET
264.90MMarket Cap-3.88P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
-13.29%-18.01M
15.65%-4.1M
-17.74%-4.03M
-74.73%-5.84M
Net income from continuing operations
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.30%-4.4M
-12.21%-5.41M
Depreciation and amortization
10.98%91K
-9.97%343K
8.33%91K
-3.23%90K
-21.57%80K
-19.61%82K
-2.81%381K
33.33%84K
-18.42%93K
-9.73%102K
Change In working capital
-104.40%-53K
64.43%1.17M
147.75%882K
-1,185.50%-2.17M
357.46%1.26M
86.09%1.2M
-31.15%714K
1,973.68%356K
143.57%200K
-144.33%-489K
-Change in receivables
--226K
-252.00%-176K
---176K
--0
--0
--0
-5,100.00%-50K
--0
--0
----
-Change in prepaid assets
-85.90%100K
255.80%645K
-1.50%-406K
151.00%205K
-18.45%137K
222.27%709K
-767.74%-414K
26.87%-400K
---402K
--168K
-Change in payables and accrued expense
-154.45%-306K
-31.47%980K
87.07%1.53M
-446.92%-2.31M
318.93%1.19M
14.93%562K
31.19%1.43M
41.87%820K
205.72%665K
-164.15%-544K
-Change in other current liabilities
-8.96%-73K
-9.13%-275K
-9.38%-70K
-9.52%-69K
-9.52%-69K
-8.06%-67K
-28.57%-252K
-14.29%-64K
-43.18%-63K
-43.18%-63K
Cash from discontinued investing activities
Operating cash flow
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
-13.29%-18.01M
15.65%-4.1M
-17.74%-4.03M
-74.73%-5.84M
Investing cash flow
Cash flow from continuing investing activities
-17,800.00%-179K
0
92.31%-1K
-1K
Net PPE purchase and sale
----
-17,800.00%-179K
--0
----
----
----
92.31%-1K
---1K
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-17,800.00%-179K
--0
---179K
--0
--0
92.31%-1K
---1K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-22.44%21.66M
324.78%68.03M
40.07M
0
39K
74.33%27.92M
16.02M
0
0
0
Net common stock issuance
-29.88%21.66M
313.34%73.92M
--43M
--0
--39K
72.69%30.88M
--17.88M
--0
--0
--0
Net other financing activities
----
-215.25%-5.89M
---2.93M
--0
--0
-58.59%-2.96M
---1.87M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-22.44%21.66M
324.78%68.03M
--40.07M
--0
--39K
74.33%27.92M
--16.02M
--0
--0
--0
Net cash flow
Beginning cash position
1,945.34%50.93M
-38.91%2.49M
115.63%14.16M
93.23%20.39M
56.38%25.88M
-38.91%2.49M
-79.40%4.08M
-23.93%6.57M
-14.52%10.55M
5.12%16.55M
Current changes in cash
-26.87%17.07M
2,524.77%48.45M
997.90%36.78M
-57.53%-6.35M
8.85%-5.33M
95.00%23.34M
87.44%-2M
15.86%-4.1M
-17.74%-4.03M
-74.73%-5.84M
Effect of exchange rate changes
-306.67%-93K
-101.94%-8K
-123.81%-5K
167.44%115K
-6.54%-163K
-91.02%45K
101.96%412K
-92.98%21K
115.52%43K
-183.33%-153K
End cash Position
162.41%67.91M
1,945.34%50.93M
1,945.34%50.93M
115.63%14.16M
93.23%20.39M
56.38%25.88M
-38.91%2.49M
-38.91%2.49M
-23.93%6.57M
-14.52%10.55M
Free cash flow
-0.20%-4.59M
-8.71%-19.58M
19.60%-3.29M
-57.53%-6.35M
8.18%-5.37M
-13.15%-4.58M
-13.20%-18.01M
15.86%-4.1M
-17.74%-4.03M
-74.73%-5.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M-13.15%-4.58M-13.29%-18.01M15.65%-4.1M-17.74%-4.03M-74.73%-5.84M
Net income from continuing operations 15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.30%-4.4M-12.21%-5.41M
Depreciation and amortization 10.98%91K-9.97%343K8.33%91K-3.23%90K-21.57%80K-19.61%82K-2.81%381K33.33%84K-18.42%93K-9.73%102K
Change In working capital -104.40%-53K64.43%1.17M147.75%882K-1,185.50%-2.17M357.46%1.26M86.09%1.2M-31.15%714K1,973.68%356K143.57%200K-144.33%-489K
-Change in receivables --226K-252.00%-176K---176K--0--0--0-5,100.00%-50K--0--0----
-Change in prepaid assets -85.90%100K255.80%645K-1.50%-406K151.00%205K-18.45%137K222.27%709K-767.74%-414K26.87%-400K---402K--168K
-Change in payables and accrued expense -154.45%-306K-31.47%980K87.07%1.53M-446.92%-2.31M318.93%1.19M14.93%562K31.19%1.43M41.87%820K205.72%665K-164.15%-544K
-Change in other current liabilities -8.96%-73K-9.13%-275K-9.38%-70K-9.52%-69K-9.52%-69K-8.06%-67K-28.57%-252K-14.29%-64K-43.18%-63K-43.18%-63K
Cash from discontinued investing activities
Operating cash flow -0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M-13.15%-4.58M-13.29%-18.01M15.65%-4.1M-17.74%-4.03M-74.73%-5.84M
Investing cash flow
Cash flow from continuing investing activities -17,800.00%-179K092.31%-1K-1K
Net PPE purchase and sale -----17,800.00%-179K--0------------92.31%-1K---1K--------
Cash from discontinued investing activities
Investing cash flow --0-17,800.00%-179K--0---179K--0--092.31%-1K---1K--0--0
Financing cash flow
Cash flow from continuing financing activities -22.44%21.66M324.78%68.03M40.07M039K74.33%27.92M16.02M000
Net common stock issuance -29.88%21.66M313.34%73.92M--43M--0--39K72.69%30.88M--17.88M--0--0--0
Net other financing activities -----215.25%-5.89M---2.93M--0--0-58.59%-2.96M---1.87M--0--0--0
Cash from discontinued financing activities
Financing cash flow -22.44%21.66M324.78%68.03M--40.07M--0--39K74.33%27.92M--16.02M--0--0--0
Net cash flow
Beginning cash position 1,945.34%50.93M-38.91%2.49M115.63%14.16M93.23%20.39M56.38%25.88M-38.91%2.49M-79.40%4.08M-23.93%6.57M-14.52%10.55M5.12%16.55M
Current changes in cash -26.87%17.07M2,524.77%48.45M997.90%36.78M-57.53%-6.35M8.85%-5.33M95.00%23.34M87.44%-2M15.86%-4.1M-17.74%-4.03M-74.73%-5.84M
Effect of exchange rate changes -306.67%-93K-101.94%-8K-123.81%-5K167.44%115K-6.54%-163K-91.02%45K101.96%412K-92.98%21K115.52%43K-183.33%-153K
End cash Position 162.41%67.91M1,945.34%50.93M1,945.34%50.93M115.63%14.16M93.23%20.39M56.38%25.88M-38.91%2.49M-38.91%2.49M-23.93%6.57M-14.52%10.55M
Free cash flow -0.20%-4.59M-8.71%-19.58M19.60%-3.29M-57.53%-6.35M8.18%-5.37M-13.15%-4.58M-13.20%-18.01M15.86%-4.1M-17.74%-4.03M-74.73%-5.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Heat List
US
Overall
Symbol
Price
% Chg

No Data